How long MACI recovery realistically takes

Most patients approaching MACI want two numbers above all else: when they can walk normally again, and when they can get back to sport. Both questions have honest, evidence-based answers — though neither comes with a single fixed date.

For the majority of patients with tibiofemoral (femoral condyle or tibial plateau) lesions, full weight-bearing is expected at 7 to 9 weeks after implantation surgery. Patellofemoral cases are handled differently: some surgeons permit immediate weight-bearing with a brace from the day after surgery, depending on the extent of the repair and any procedures performed at the same time. These milestones come from a 2020 Delphi consensus in which a panel of orthopaedic surgeons reached agreement on rehabilitation guidelines after MACI across four key domains.

For knee movement, the same consensus identified 90° of flexion by Week 4 as the target, progressing to full range of motion by weeks 7 to 9.

Return to desk-based work and light daily activities tends to follow those same physical milestones. Return to sport is a longer journey — typically 9 to 18 months from implantation, varying with activity level, lesion site, and individual progress.

These are anchor points, not a rigid prescription. Recovery after MACI is deliberately staged and individually paced; the milestones provide a structured framework, but the rate of progression between them is tailored to each patient's joint, lesion, and response.

When the recovery clock actually starts

MACI is a two-stage procedure, and knowing where Stage 1 ends and Stage 2 begins changes how patients plan the months ahead.

Stage 1 is a short keyhole procedure to harvest a small sample of cartilage cells from the knee. Those cells are sent to a specialist laboratory, where they are cultured and seeded onto a collagen membrane over the course of four to six weeks. Stage 2 is the implantation surgery — the operation in which that prepared membrane is fixed into the cartilage defect.

The week-by-week rehabilitation clock starts from Stage 2, not from the biopsy. Stage 1 carries its own brief recovery — most patients are mobile within days — but that initial recovery should not be counted as part of the post-implantation protocol described in this guide.

In practical terms, this means the full timeline from first procedure to return to sport spans considerably longer than the implantation recovery alone. Patients who understand the two-stage structure are better placed to arrange time off work, travel commitments, and home support around both operations, not just the second.

Weeks 1–6: protecting the graft

Protecting the newly implanted cells is the dominant priority from day one. The graft needs mechanical stability to integrate — too much load too soon risks displacing the collagen membrane before the chondrocytes have had time to adhere to the prepared bone beneath.

For tibiofemoral lesions, crutches are standard from the outset, with the exact partial weight-bearing schedule set by the treating surgeon according to lesion size, site, and any concurrent procedures. Patellofemoral patients may follow a different path — as covered when discussing the overall timeline — with some bearing weight from the day after surgery with a brace. Within those constraints, movement is actively encouraged: the 90° flexion consensus target, already established as the Week 4 milestone, has to be reached while avoiding the shear forces that could disturb the membrane. The physiotherapist sets the rate of ROM progression according to pain, swelling, and tissue response, not a fixed daily schedule.

Swelling control runs alongside movement work throughout this phase. Elevation, ice, and compression limit joint effusion and reduce the fluid pressure that a reactive knee generates against the repair site.

The most significant addition to early MACI rehabilitation in recent years is blood flow restriction (BFR) training. A cuff applied to the upper thigh restricts venous outflow during low-load exercise, creating a local metabolic stimulus strong enough to preserve quadriceps muscle mass without the joint loading that conventional strengthening would require. BFR allows meaningful quad work from the early weeks — when the graft remains fragile — rather than waiting until the full weight-bearing phase allows heavier exercise. This shift away from the muscle wastage that historically accompanied prolonged crutch use is one of the clearest practical gains in modern cartilage rehabilitation.

The 2024 randomised trial comparing six-week and eight-week weight-bearing pathways is worth revisiting here for a specific reason: both arms followed structured, physiotherapist-supervised programmes with criteria-based progression. The accelerated group did not simply load the knee earlier and independently — the supervision was integral. That distinction reinforces the core principle of this phase: goals and milestones provide the framework, but safe progression depends on individual clinical assessment at each step.

Weeks 7–12: loading the knee and reclaiming movement

By week seven, the rehabilitation focus shifts decisively from protecting the graft to rebuilding function. For tibiofemoral lesions, the Delphi consensus places full weight-bearing between weeks 7 and 9 — but this is a clinical checkpoint, not a date circled in advance. A surgeon or physiotherapist confirms readiness based on pain, swelling, and movement quality; patients who are progressing well reach it on the earlier side of that window, and those with larger defects or slower tissue responses may need the full nine weeks.

Walking without crutches and managing a full flight of stairs without compensating are the two practical markers that signal the knee is genuinely tolerating load, not just enduring it. ROM should be continuing to advance toward full flexion throughout this period — if stiffness is limiting daily movement by week 10 or 11, a physiotherapy review is appropriate rather than waiting it out.

Gait retraining becomes a central focus once crutches are no longer needed. Many patients accumulate subtle movement compensations during the non-weight-bearing phase — a shortened stride, hip-drop, or offloading habit — that persist without targeted correction. Progressive strengthening, including shallow squats and leg press at controlled depth, begins building the quad and hamstring capacity needed for higher-demand activities later.

Return to desk-based work and routine daily activities — light shopping, driving an automatic vehicle, cooking — is realistic within this phase for most patients, though the exact timing depends on lesion location and what concurrent procedures were performed. Physically demanding roles take considerably longer and are assessed separately.

Swelling remains the most reliable real-time guide. A knee that is consistently puffy by the end of the day is signalling that progression is outpacing recovery — slowing the loading programme for a few days is preferable to setting the graft back by weeks.

Return to sport after MACI

Among competitive footballers, 83% returned to sport after ACI or MACI, with 80% reaching their prior competitive level; at five years, 87–100% maintained the ability to play. Those figures are among the strongest in cartilage repair literature and reflect what a well-selected patient, properly rehabilitated, can achieve.

The wider picture is more varied. Across mixed patellofemoral cohorts combining osteochondral allograft and ACI/MACI procedures, the overall return-to-sport rate falls to approximately 54%. Larger lesion area and increasing age are the two clearest predictors of a lower likelihood of returning — both factors that a consultant will weigh honestly when setting expectations at the outset rather than at the point of discharge.

Citing a single 'return-to-sport week' would misrepresent what the evidence actually shows. A 2025 systematic review of 85 studies published between 2014 and 2024 found that only 15.3% reported RTS as a postoperative percentage, and more than one in five used non-validated custom outcome tools. That inconsistency makes cross-study comparison unreliable, and it is the reason that recovery guides framing RTS around a specific week should be read cautiously.

In practice, return to sport is a phased process gated by functional criteria, not calendar dates alone. Light jogging typically precedes sport-specific drills; contact or competitive play comes last, once strength symmetry, hop test scores, and the absence of pain and swelling all confirm the knee is ready. That sequence can span anywhere from nine to eighteen months depending on the sport, the defect, and how the individual knee responds at each stage.

The clearest clinical principle is that the return-to-sport plan follows the knee rather than the clock. A consultant-supervised programme uses objective measures — quadriceps symmetry indices, single-leg hop distances, swelling at rest and after loading — to determine when each threshold has been met, rather than releasing a patient to sport on a predetermined date.

What makes your timeline different from the textbook

Several factors consistently shift individual timelines away from consensus averages — and understanding them explains why clinicians review progress at each stage rather than handing out a fixed timetable on discharge day.

Lesion location is the most consequential single variable. Patellofemoral patients may bear weight immediately after surgery with bracing in place — a protocol that diverges markedly from the 7–9 week window applied to tibiofemoral defects, as established by the 2020 Delphi consensus. The phase labels may look similar on paper, but the content of each phase differs considerably between the two groups.

Defect size matters in parallel. MACI targets lesions typically in the 2–10 cm² range, and larger defects are associated both with longer rehabilitation trajectories and with a lower probability of returning to competitive sport — patterns evident in published data across patellofemoral cohorts.

Prior marrow-stimulation procedures such as microfracture can alter the subchondral bone plate in ways that influence graft integration, meaning a patient's full surgical history feeds into the clinical calculation alongside current anatomy.

Individual characteristics — age, baseline muscle mass, pre-operative function, and activity goals — shape how quickly each milestone is actually reached. A patient in their late thirties, well-conditioned before surgery and targeting recreational running, will typically progress differently from someone older with a larger defect and a more sedentary baseline.

The Delphi consensus reflects multi-surgeon agreement across a broad population; it is a calibrated reference point, not a universal prescription. Real-world protocols are adjusted at each clinical review as the knee demonstrates what it is ready to tolerate.

1. [1] Consensus on Rehabilitation Guidelines among Orthopedic Surgeons in the United States following Use of Third-Generation Articular Cartilage Repair (MACI) for Treatment of Knee Cartilage Lesions. (2020). https://doi.org/10.1177/1947603520968876 https://doi.org/10.1177/1947603520968876
2. [2] A Randomized Controlled Trial Evaluating an Accelerated Weight-Bearing Rehabilitation Pathway after Matrix-Induced Autologous Chondrocyte Implantation for Symptomatic Knee Cartilage Defects. (2024). https://doi.org/10.31189/2165-7629-13-s2.316 https://doi.org/10.31189/2165-7629-13-s2.316
3. [3] The Evolution of Rehabilitation and Return to Sport Following Cartilage Surgery. (2023). https://doi.org/10.26603/001c.77508 https://doi.org/10.26603/001c.77508
4. [4] Comparison of Clinical Outcomes and Return to Sport Rates Between OCA and ACI/MACI for Patellofemoral Articular Cartilage Lesions. (2024). https://doi.org/10.1177/2325967124s00050 https://doi.org/10.1177/2325967124s00050
5. [5] Comparison of Three Different Techniques for the Treatment of Cartilage Lesions—MACI vs AMIC and Arthroscopic Minced Cartilage—A 2-Year Follow-Up. (2025). https://doi.org/10.3390/jcm14072194 https://doi.org/10.3390/jcm14072194
6. [6] High Variability in Return-to-Sport Assessment After Autologous Chondrocyte Implantation of the Knee: A Systematic Review. (2025). https://doi.org/10.1177/19476035251379214 https://doi.org/10.1177/19476035251379214